|

Identify microRNAs in Cachexia in Pancreatic Carcinoma

RECRUITINGSponsored by University of Oklahoma
Actively Recruiting
SponsorUniversity of Oklahoma
Started2022-12-07
Est. completion2026-05-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

The purpose of this study is to determine the proportion of pancreatic patients who experience weight loss and cachexia, and to identify any differences in the genes between patient groups.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Male or female patient, who is ≥ 18 years old at the time of informed consent.
2. Patients with operable pancreatic tumors diagnosed in the last 12 months prior to consent with clinical discretion or pathology confirmed as adenocarcinoma.
3. Patient has stage I or higher disease who is considered a candidate for surgical resection of pancreatic cancer, with or without neoadjuvant chemotherapy.
4. Ability to provide written informed consent and HIPAA authorization.

Exclusion Criteria:

1. Patients with pancreatic adenocarcinoma who do not meet the criteria for surgical resection.
2. Patient has cancer diagnosis other than primary pancreatic adenocarcinoma.

Conditions3

CancerResectable Pancreatic AdenocarcinomaWeight Loss

Locations1 site

Stephenson Cancer Center
Oklahoma City, Oklahoma, 73117
Ajay Jain, MDAjay-Jain@ouhsc.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.